ENaC inhibitors for the treatment of cystic fibrosis

Pharmaceutical patent analyst

Volumn 4, Issue 1, 2015, Pages 17-27

  Butler, Rebecca ^a   Hunt, Thomas ^a   Smith, Nichola J ^a  

^a UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL KINASE; EPITHELIAL SODIUM CHANNEL; EPITHELIAL SODIUM CHANNEL BLOCKING AGENT;

ANIMAL; ANTAGONISTS AND INHIBITORS; CYSTIC FIBROSIS; DRUG INDUSTRY; HUMAN; METABOLISM; PATENT;

ANIMALS; CYSTIC FIBROSIS; DIACYLGLYCEROL KINASE; DRUG INDUSTRY; EPITHELIAL SODIUM CHANNEL BLOCKERS; EPITHELIAL SODIUM CHANNELS; HUMANS; PATENTS AS TOPIC;

EID: 85050578543     PISSN: None     EISSN: 20468962     Source Type: Journal    
DOI: 10.4155/ppa.14.51     Document Type: Review

References (0)